These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10411462)
1. Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers. Caliceti P; Schiavon O; Veronese FM Bioconjug Chem; 1999; 10(4):638-46. PubMed ID: 10411462 [TBL] [Abstract][Full Text] [Related]
2. Immunological properties of uricase conjugated to neutral soluble polymers. Caliceti P; Schiavon O; Veronese FM Bioconjug Chem; 2001; 12(4):515-22. PubMed ID: 11459455 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine). Schiavon O; Caliceti P; Ferruti P; Veronese FM Farmaco; 2000 Apr; 55(4):264-9. PubMed ID: 10966157 [TBL] [Abstract][Full Text] [Related]
4. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and biopharmaceutical properties of PEGylated uricase. Freitas Dda S; Spencer PJ; Vassão RC; Abrahão-Neto J Int J Pharm; 2010 Mar; 387(1-2):215-22. PubMed ID: 19969053 [TBL] [Abstract][Full Text] [Related]
6. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice. Fischer D; Osburg B; Petersen H; Kissel T; Bickel U Drug Metab Dispos; 2004 Sep; 32(9):983-92. PubMed ID: 15319340 [TBL] [Abstract][Full Text] [Related]
7. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit. Khattab MA; Farr SJ; Taylor G; Kellaway IW J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819 [TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. Gillies ER; Dy E; Fréchet JM; Szoka FC Mol Pharm; 2005; 2(2):129-38. PubMed ID: 15804187 [TBL] [Abstract][Full Text] [Related]
9. Highly efficient gene transfer with degradable poly(ester amine) based on poly(ethylene glycol) diacrylate and polyethylenimine in vitro and in vivo. Park MR; Kim HW; Hwang CS; Han KO; Choi YJ; Song SC; Cho MH; Cho CS J Gene Med; 2008 Feb; 10(2):198-207. PubMed ID: 18064729 [TBL] [Abstract][Full Text] [Related]
10. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies. Bomalaski JS; Holtsberg FW; Ensor CM; Clark MA J Rheumatol; 2002 Sep; 29(9):1942-9. PubMed ID: 12233890 [TBL] [Abstract][Full Text] [Related]
11. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019 [TBL] [Abstract][Full Text] [Related]
12. Characterization, efficacy, pharmacokinetics, and biodistribution of 5kDa mPEG modified tetrameric canine uricase variant. Zhang C; Fan K; Luo H; Ma X; Liu R; Yang L; Hu C; Chen Z; Min Z; Wei D Int J Pharm; 2012 Jul; 430(1-2):307-17. PubMed ID: 22503989 [TBL] [Abstract][Full Text] [Related]
13. Effects of modification of amino groups with poly(ethylene glycol) on a recombinant uricase from Bacillus fastidiosus. Zhang C; Yang X; Feng J; Yuan Y; Li X; Bu Y; Xie Y; Yuan H; Liao F Biosci Biotechnol Biochem; 2010; 74(6):1298-301. PubMed ID: 20530883 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Schluep T; Cheng J; Khin KT; Davis ME Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526 [TBL] [Abstract][Full Text] [Related]
15. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase. Abuchowski A; Karp D; Davis FF J Pharmacol Exp Ther; 1981 Nov; 219(2):352-4. PubMed ID: 7288624 [TBL] [Abstract][Full Text] [Related]
16. A new practical system for evaluating the pharmacological properties of uricase as a potential drug for hyperuricemia. Feng J; Li X; Yang X; Zhang C; Yuan Y; Pu J; Zhao Y; Xie Y; Yuan H; Bu Y; Liao F Arch Pharm Res; 2010 Nov; 33(11):1761-9. PubMed ID: 21116779 [TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of 111In-labeled uricase conjugated with charged dextrans and polyethylene glycol. Fujita T; Yasuda Y; Takakura Y; Hashida M; Sezaki H J Pharmacobiodyn; 1991 Nov; 14(11):623-9. PubMed ID: 1725532 [TBL] [Abstract][Full Text] [Related]
18. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. Sant S; Poulin S; Hildgen P J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249 [TBL] [Abstract][Full Text] [Related]
19. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer. Shan X; Liu C; Yuan Y; Xu F; Tao X; Sheng Y; Zhou H Colloids Surf B Biointerfaces; 2009 Sep; 72(2):303-11. PubMed ID: 19450955 [TBL] [Abstract][Full Text] [Related]
20. Development of poly(ethylene glycol) conjugated lactoferrin for oral administration. Nojima Y; Suzuki Y; Iguchi K; Shiga T; Iwata A; Fujimoto T; Yoshida K; Shimizu H; Takeuchi T; Sato A Bioconjug Chem; 2008 Nov; 19(11):2253-9. PubMed ID: 18834167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]